Thank you Hellouser. I appreciate that.I go a bit too crazy for the approval here, but... until I bleed a lot. Most people will have a few small spots of blood here and there though.
Thank you Hellouser. I appreciate that.I go a bit too crazy for the approval here, but... until I bleed a lot. Most people will have a few small spots of blood here and there though.
@hellouser how long have you been dermarolling and have you seen any results?I go a bit too crazy for the approval here, but... until I bleed a lot. Most people will have a few small spots of blood here and there though.
I wonder if the percentage of AA patients that didnt respond also suffer from Androgenetic Alopecia?
Completely, incompletely, I think the cure for longevity will be a hard thing to come by, too. I agree with Cotsarelis in that cures have been few and far between. Big pharma has spent foolishly on blue chip shareholder dividends since the 1980s and very few blockbuster drugs to show for it. We're relying on starving hair biologists the likes of Christiano and Cotsarelis for understanding the genetic code of hairloss. Tsuji is promising a lot by 2020. I hope he doesnt turn out to be another Coen Gho, as talented a HTdoctor as he is today.
I just want an effective treatment as do we all. A cure? I don't think there will be very many of those soon. I've read Follica's upcoming clinical trial will be categorized as "open" and testing for effectiveness of the treatment across all norwoods and age groups as opposed to testing for efficacy, or a tighter protocol limted to just the low norwood numbers. Sounds like they want to hard test their treatment platform against the general public with respect to Androgenetic Alopecia?
I disagree, I think the "cure" is close but it all depends on the science, the method. Only Tsuji grasps this concept at the moment (well he is the only one running for clinical trials now). And he has a very good chance.
Drugs? No way. No proper model, Androgenetic Alopecia progressive disease that might even end in destruction of the hair follicle, observations don't support it, drugs limited due to their pharmacokinetics and side effects, androgens + AR always active etc.
Thanks, I don't there is enough interest in JAK inhibitors these days though.I'd be willing to contribute to a crowdfund for you, not sure about others.
Are JAK inhibitors safe in terms of immune suppression? Tofactinib has issues with that if I recall.